Beijing Chunlizhengda Medical Instruments Co., Ltd.

Total Valuation

Beijing Chunlizhengda Medical Instruments Co., Ltd. carries a market capitalization of 5.45B, placing it among publicly traded companies globally. Its enterprise value stands at 1.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Beijing Chunlizhengda Medical Instruments Co., Ltd. currently has 383.57M shares outstanding.

Valuation Ratios

Beijing Chunlizhengda Medical Instruments Co., Ltd. trades at a trailing price-to-earnings ratio of 57.83. The price-to-sales ratio is 12.57, and the price-to-book ratio stands at 1.99.

Enterprise Valuation

On an enterprise value basis, Beijing Chunlizhengda Medical Instruments Co., Ltd. trades at an EV/EBITDA multiple of 22.60 and an EV/FCF ratio of 73.92. The EV/Sales ratio of 4.55 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 22.60 provides insight into valuation relative to core operating earnings.

Financial Position

Beijing Chunlizhengda Medical Instruments Co., Ltd. maintains a current ratio of 4.16, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.03, indicating conservative leverage, while an interest coverage ratio of 5,745.25 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Beijing Chunlizhengda Medical Instruments Co., Ltd. has paid 2.85M in income taxes, reflecting an effective tax rate of 4.97.

Stock Price Statistics

Beijing Chunlizhengda Medical Instruments Co., Ltd.'s stock has declined approximately -30.89124% over the past 52 weeks. The 50-day moving average sits at 9.98, while the 200-day moving average is 13.82.

Income Statement

Over the trailing twelve months, Beijing Chunlizhengda Medical Instruments Co., Ltd. generated 251.45M in revenue and converted that into 54.64M in net income, yielding earnings per share of 0.14. EBITDA reached 50.58M, while operating income came in at 50.58M.

Balance Sheet

Beijing Chunlizhengda Medical Instruments Co., Ltd. holds 2.02B in cash and equivalents against 920,301.52 in total debt, resulting in a net debt position of -1.28B. Total book value stands at 1.59B, with working capital of 2.27B providing operational flexibility.

Cash Flow

After subtracting -15.46M in capital expenditures, free cash flow totaled -15.46M - equivalent to -0.04 per share.

Margins

Beijing Chunlizhengda Medical Instruments Co., Ltd. operates with a gross margin of 66.96, reflecting its pricing power and cost economics. The operating margin of 20.11 and net profit margin of 21.73 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Beijing Chunlizhengda Medical Instruments Co., Ltd.'s most recent stock split took place on April 20, 2020 with a 2:5 split ratio.

Scores

Beijing Chunlizhengda Medical Instruments Co., Ltd. posts an Altman Z-Score of 3.72, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.